2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity
Authors:
- Marcin DropMDMarcin Drop
- Vittorio CanaleVCVittorio Canale
- Séverine Chaumont-DubelSCSéverine Chaumont-Dubel
- Rafał KurczabRKRafał Kurczab
- Grzegorz SatałaGSGrzegorz Satała
- Xavier BantreilXBXavier Bantreil
- Maria WalczakMWMaria Walczak
- Paulina Koczurkiewicz-AdamczykPKPaulina Koczurkiewicz-Adamczyk
- Gniewomir LataczGLGniewomir Latacz
Open Access
- 11 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 12 (7) , 1228-1240
Abstract
Serotonin type 6 receptor (5-HT6R) has gained particular interest as a promising target for treating cognitive deficits, given the positive effects of its antagonists in a wide range of memory impairment paradigms. Herein, we report on degradation of the 1H-pyrrolo[3,2-c]quinoline scaffold to provide the 2-phenyl-1H-pyrrole-3-carboxamide, which is devoid of canonical indole-like skeleton and retains recognition of 5-HT6R. This modification has changed the compound’s activity at 5-HT6R-operated signaling pathways from neutral antagonism to inverse agonism. The study identified compound 27 that behaves as an inverse agonist of the 5-HT6R at the Gs and Cdk5 signaling pathways. Compound 27 showed high selectivity and metabolic stability and was brain penetrant. Finally, 27 reversed scopolamine-induced memory decline in the novel object recognition test and exhibited procognitive properties in the attentional set-shifting task in rats. In light of these findings, 27 might be considered for further evaluation as a new cognition-enhancing agent, while 2-phenyl-1H-pyrrole-3-carboxamide might be used as a template for designing 5-HT6R inverse agonists.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-17-CE16-0013-01 and ANR-17-CE16-0010-01)
- Narodowe Centrum Nauki (2016/21/B/NZ7/01742)
- Montpellier University of Excellence (iSITE MUSE)
- Priority Research Area qLife under the program ?Excellence Initiative ? Research University? at the Jagiellonian University in Krakow
This publication has 45 references indexed in Scilit:
- International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and FunctionPharmacological Reviews, 2021
- The 5-HT6 receptor interactome: New insight in receptor signaling and its impact on brain physiology and pathologiesNeuropharmacology, 2020
- Early 5‐HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuseEMBO Molecular Medicine, 2020
- Dynamic interactions of the 5-HT 6 receptor with protein partners control dendritic tree morphogenesisScience Signaling, 2020
- Antagonism of the 5-HT 6 receptor – Preclinical rationale for the treatment of Alzheimer's diseaseNeuropharmacology, 2017
- Cognitive decline and dementia in Down syndromeCurrent Opinion in Psychiatry, 2017
- Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growthNature Chemical Biology, 2014
- 5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaEMBO Molecular Medicine, 2012
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyNature Reviews Drug Discovery, 2012
- 5-HT6 receptor and cognitionCurrent Opinion in Pharmacology, 2011